ERBB2 and melanoma: In vitro cytotoxicity assay showed that anti-HER2 antibody had no inhibitory effect on melanoma cell lines, but HER2Bi-armed ATC provided significant anti-proliferative and cytotoxic activity against Malme-3M cells.